These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 16904981)
1. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4. Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981 [TBL] [Abstract][Full Text] [Related]
2. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity. Shi Q; Wang D; Hadley GA; Bingaman AW; Bartlett ST; Farber DL Diabetes; 2004 Sep; 53(9):2338-45. PubMed ID: 15331543 [TBL] [Abstract][Full Text] [Related]
3. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239 [TBL] [Abstract][Full Text] [Related]
4. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice. Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822 [TBL] [Abstract][Full Text] [Related]
5. Impact of donor immune cells in pancreatic islet transplantation. Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170 [TBL] [Abstract][Full Text] [Related]
6. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice. Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366 [TBL] [Abstract][Full Text] [Related]
7. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice. Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619 [TBL] [Abstract][Full Text] [Related]
8. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435 [TBL] [Abstract][Full Text] [Related]
9. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. Han HS; Jun HS; Utsugi T; Yoon JW J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968 [TBL] [Abstract][Full Text] [Related]
10. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473 [TBL] [Abstract][Full Text] [Related]
11. Importance of donor-derived lymphocytes in the protection of pancreaticoduodenal or islet grafts from recurrent autoimmunity: a role for RT6+NKR-P1+ T cells. Tori M; Ito T; Kitagawa-Sakakida S; Nozawa M; Matsuda H; Shirakura R Transplantation; 2000 Jul; 70(1):32-8. PubMed ID: 10919571 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154 [TBL] [Abstract][Full Text] [Related]
13. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513 [TBL] [Abstract][Full Text] [Related]
14. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice. Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462 [TBL] [Abstract][Full Text] [Related]
15. Viral IL-10-mediated immune regulation in pancreatic islet transplantation. Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104 [TBL] [Abstract][Full Text] [Related]
16. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection. Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223 [TBL] [Abstract][Full Text] [Related]
17. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299 [TBL] [Abstract][Full Text] [Related]
18. Islet transplantation in the discordant tilapia-to-mouse model: a novel application of alginate microencapsulation in the study of xenograft rejection. Dickson BC; Yang H; Savelkoul HF; Rowden G; van Rooijen N; Wright JR Transplantation; 2003 Mar; 75(5):599-606. PubMed ID: 12640296 [TBL] [Abstract][Full Text] [Related]
19. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice. Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017 [TBL] [Abstract][Full Text] [Related]
20. Distinct regulation of autoreactive CD4 T cell expansion by interleukin-4 under conditions of lymphopenia. Hill NJ; Stotland AB; Sarvetnick NE J Leukoc Biol; 2007 Mar; 81(3):757-65. PubMed ID: 17164429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]